BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2023 2:04:50 AM | Browse: 216 | Download: 616
 |
Received |
|
2023-05-07 21:07 |
|
Peer-Review Started |
|
2023-05-07 21:09 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2023-07-04 08:33 |
|
Revised |
|
2023-07-12 18:01 |
|
Second Decision |
|
2023-08-08 02:53 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-08-08 07:35 |
|
Articles in Press |
|
2023-08-08 07:35 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-08-16 12:55 |
|
Publish the Manuscript Online |
|
2023-08-22 02:04 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Readmission rates and outcomes in adults with and without COVID-19 following inpatient chemotherapy admission: A nationwide analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Philip Kanemo, Keffi Mubarak Musa, Vaishali Deenadayalan, Rafaella Litvin, Olubunmi Emmanuel Odeyemi, Abdultawab Shaka, Naveen Baskaran and Hafeez Shaka |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Keffi Mubarak Musa, MBBS, Doctor, Doctor, Research Assistant, Department of Medicine, Ahmadu Bello University Teaching Hospital, Flat 8, street A, Transit Camp, Shika, Zaria 88445, Kaduna, Nigeria. keffimubarakmusa@gmail.com |
| Key Words |
Chemotherapy; Coronavirus disease 2019 pandemic; Nationwide readmission database; Readmission rates; Cancer; Healthcare cost |
| Core Tip |
Our nationwide study explored care for patients undergoing inpatient chemotherapy during the coronavirus disease 2019 (COVID-19) pandemic. It is the first to analyze factors surrounding hospitalization for such patients. We found a higher readmission rate during the pandemic, with comorbidities posing a greater risk. Surprisingly, COVID-19 infection was not significantly linked to readmission. Hospitalization costs rose, averaging 22952.00 dollars. Our findings would interest the scientific community, hospital managers, and health policymakers. Understanding the pandemic's impact on cancer patients' care can lead to mitigating health policies. |
| Publish Date |
2023-08-22 02:04 |
| Citation |
Kanemo P, Musa KM, Deenadayalan V, Litvin R, Odeyemi OE, Shaka A, Baskaran N, Shaka H. Readmission rates and outcomes in adults with and without COVID-19 following inpatient chemotherapy admission: A nationwide analysis. World J Clin Oncol 2023; 14(8): 311-323 |
| URL |
https://www.wjgnet.com/2218-4333/full/v14/i8/311.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v14.i8.311 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
